Publications by authors named "Veronique Barbalat"

Article Synopsis
  • ICU-acquired infections (IAI) increase hospital stays, costs, and mortality, and current biomarkers aren’t effective in identifying patients at risk.
  • A study analyzed the mRNA expression of two biomarkers, CD74 and IL10, in 725 ICU patients to see if they could predict IAI occurrence.
  • Results indicated that higher levels of CD74 and IL10 were significantly associated with a higher risk of developing IAI, suggesting they could be useful for identifying at-risk patients.
View Article and Find Full Text PDF

Introduction: Septic syndromes remain the leading cause of mortality in intensive care units (ICU). Septic patients rapidly develop immune dysfunctions, the intensity and duration of which have been linked with deleterious outcomes. Decreased mRNA expressions of major histocompatibility complex (MHC) class II-related genes have been reported after sepsis.

View Article and Find Full Text PDF

The rapid development in septic patients of features of marked immunosuppression associated with increased risk of nosocomial infections and mortality represents the rational for the initiation of immune targeted treatments in sepsis. However, as there is no clinical sign of immune dysfunctions, the current challenge is to develop biomarkers that will help clinicians identify the patients that would benefit from immunotherapy and monitor its efficacy. Using an in vitro model of endotoxin tolerance (ET), a pivotal feature of sepsis-induced immunosuppression in monocytes, we identified using gene expression profiling by microarray a panel of transcripts associated with the development of ET which expression was restored after immunostimulation with interferon-gamma (IFN-γ).

View Article and Find Full Text PDF

Introduction: It is now well accepted that sepsis is associated with the development of a pronounced immunosuppressive state, characterized by severe immune alterations (e.g. reduced proliferative capacity, endotoxin tolerance, apoptosis) participating in increased mortality and susceptibility to nosocomial infections.

View Article and Find Full Text PDF

Genomic DNA extraction for genotyping analysis is performed from blood samples and is time consuming. We describe a more rapid DNA extraction method, "DBS-miniMAG", that combines filter paper dried blood spots (DBS) with the NucliSens miniMAG semi-automated instrument (bioMérieux). To assess the performance of this method, a post-PCR HLA-DR shared epitope (SE) oligotyping assay was used as a read-out in a cohort of 72 arthritis patients.

View Article and Find Full Text PDF